カテゴリ： GlobalData, アメリカ, 企業調査

NuVasive Inc (NUVA)-医療機器分野：企業M&A・提携分析

◆英語タイトル：NuVasive Inc (NUVA) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011067
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月21日
◆ページ数：73
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimally-disruptive spine procedures in all regions of the spine and from various surgical approaches. MAS platform combines three product categories, namely, MaXcess retractors, its specialized implants and fixation products and its nerve monitoring systems and service offerings. The company’s products find application in spine fusion surgery, including biologics used to aid in the spinal fusion process. NuVasive is headquartered in San Diego, California, the US.

NuVasive Inc (NUVA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
NuVasive Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NuVasive Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NuVasive Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NuVasive Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
NuVasive Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
NuVasive Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Ellipse Technologies Secures US$17.6 Million In Series C Financing 11
Ellipse Technologies Secures US$15 Million In Financing 12
Partnerships 13
NuVasive Enters Into Licensing Agreement With AlloSource 13
Equity Offering 14
Ellipse Technologies Withdraws IPO for up to USD75 Million 14
Debt Offering 15
NuVasive Raises USD650 Million in Private Placement of 2.25% Notes Due 2021 15
NuVasive Completes Underwritten Public Offering Of Senior Notes Due 2017 For US$402.5 Million 17
Acquisition 18
NuVasive to Acquire SafePassage 18
NuVasive Acquires Vertera Spine 19
NuVasive Acquires Biotronic NeuroNetwork for USD98 Million 20
NuVasive to Acquire Mega Surgical 21
NuVasive Acquires Ellipse Technologies 22
Biotronic NeuroNetwork Acquires Neurophysiology Associates, Provider Of Intraoperative Monitoring Services 23
NuVasive Acquires ANC, Maker Of Spine Implant, For US$4.5 Million 24
NuVasive Completes Acquisition Of Impulse Monitoring For US$80 Million 25
Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring 26
NuVasive Inc – Key Competitors 27
NuVasive Inc – Key Employees 28
NuVasive Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 31
Strategy And Business Planning 31
Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters 31
Financial Announcements 32
Oct 24, 2017: NuVasive Reports Third Quarter 2017 Financial Results 32
Jul 27, 2017: NuVasive Reports Second Quarter 2017 Financial Results 33
Apr 25, 2017: NuVasive Announces First Quarter 2017 Financial Results 34
Feb 09, 2017: NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results 35
Jan 09, 2017: NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook 37
Oct 25, 2016: NuVasive Reports Third Quarter 2016 Financial Results 38
Jul 26, 2016: NuVasive Reports Second Quarter 2016 Financial Results 40
Apr 26, 2016: NuVasive Reports First Quarter 2016 Financial Results 42
Feb 11, 2016: NuVasive Reports Fourth Quarter and Full Year 2015 Financial Results 43
Jan 12, 2016: NuVasive Announces Select Preliminary Full-Year 2015 Financial Results and Reiterates 2016 Outlook 45
Corporate Communications 46
Dec 14, 2017: NuVasive Appoints Experienced Spine Executive Michael Piccirillo To Lead New Global Surgeon Education Platform 46
Aug 15, 2017: NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer 47
Jul 27, 2017: NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals 48
Jun 01, 2017: NuVasive Appoints Skip Kiil As Executive Vice President, International 49
Oct 03, 2016: NuVasive Appoints Joan Stafslien as Executive Vice President, General Counsel 50
Sep 12, 2016: NuVasive Names Jason M. Hannon President and Chief Operating Officer; Patrick S. Miles Assumes Role of Vice Chairman 51
Aug 01, 2016: Michael D. O’Halleran and Patrick S. Miles Elected to NuVasive Board of Directors 52
Feb 11, 2016: NuVasive Elects Robert F. Friel and Donald J. Rosenberg to Board of Directors 53
Legal and Regulatory 54
Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 54
Product News 55
Oct 25, 2017: NuVasive Unveils Latest Innovation At NASS 2017 55
Jul 10, 2017: NuVasive Leading Sponsor Of IMAST 2017 And Hosting Workshops Featuring Advanced Technologies 57
Jun 05, 2017: NuVasive Magnetic, Non-Invasive Platforms Featured In The Journal Of Orthopaedic Trauma Supplement 58
May 02, 2017: NuVasive Announces Sponsorship Of EPOSNA 2017 And Launches New Monthly Pediatric Spinal Deformity Podcast 59
Mar 20, 2017: New Evidence-Based Recommendation Released From NICE (U.K.) For Lateral Interbody Fusion 60
Dec 29, 2016: NuVasive to Resume XLIF Procedures in Japan in First Quarter 2017 61
Oct 25, 2016: NuVasive First-to-Market With New Spine Innovations Featured at NASS 2016 62
Jul 12, 2016: NuVasive to Feature Industry-Leading Portfolio at 23rd International Meeting on Advanced Spine Technologies 64
May 13, 2016: NuVasive to Feature Game-Changing, Integrated Spine Solutions at SpineWeek 2016 65
Apr 28, 2016: NuVasive Extends Spine Innovator Leadership Position, Launches New Solutions at 84th AANS Annual Scientific Meeting 67
03/09/2016: NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan 68
Product Approvals 69
Mar 09, 2016: NuVasive Announces Regulatory Approval of Reline(TM) Posterior Fixation Technology in Japan 69
Other Significant Developments 70
Oct 23, 2017: NuVasive Extends Its Leadership As Lateral Spine Technology Innovator With New Lateral Single-Position Surgery Procedure 70
May 22, 2017: NuVasive Announces Educational Initiatives In Support Of Spine’s Fastest Growing Spinal Deformity Portfolio 72
Appendix 73
Methodology 73
About GlobalData 73
Contact Us 73
Disclaimer 73

List of Tables
NuVasive Inc, Medical Equipment, Key Facts, 2016 2
NuVasive Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
NuVasive Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
NuVasive Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
NuVasive Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
NuVasive Inc, Deals By Market, 2011 to YTD 2017 9
NuVasive Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ellipse Technologies Secures US$17.6 Million In Series C Financing 11
Ellipse Technologies Secures US$15 Million In Financing 12
NuVasive Enters Into Licensing Agreement With AlloSource 13
Ellipse Technologies Withdraws IPO for up to USD75 Million 14
NuVasive Raises USD650 Million in Private Placement of 2.25% Notes Due 2021 15
NuVasive Completes Underwritten Public Offering Of Senior Notes Due 2017 For US$402.5 Million 17
NuVasive to Acquire SafePassage 18
NuVasive Acquires Vertera Spine 19
NuVasive Acquires Biotronic NeuroNetwork for USD98 Million 20
NuVasive to Acquire Mega Surgical 21
NuVasive Acquires Ellipse Technologies 22
Biotronic NeuroNetwork Acquires Neurophysiology Associates, Provider Of Intraoperative Monitoring Services 23
NuVasive Acquires ANC, Maker Of Spine Implant, For US$4.5 Million 24
NuVasive Completes Acquisition Of Impulse Monitoring For US$80 Million 25
Impulse Monitoring Acquires Great Lakes Intraoperative Neuromonitoring 26
NuVasive Inc, Key Competitors 27
NuVasive Inc, Key Employees 28
NuVasive Inc, Other Locations 29
NuVasive Inc, Subsidiaries 29

★海外企業調査レポート[NuVasive Inc (NUVA)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Corcept Therapeutics Inc (CORT)：企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sunwin Stevia International Inc (SUWN)：企業の財務・戦略的SWOT分析
    Sunwin Stevia International Inc (SUWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Cytune Pharma SAS-製薬・医療分野：企業M&A・提携分析
    Summary Cytune Pharma SAS (Cytune) is a developer of immunotherapeutic agents for the treatment of cancer and infectious diseases. The company’s product portfolio includes recombinant proteins and monoclonal antibodies. Its CYP0150 is a recombinant protein, which decreases metastasis numbers, tumor …
  • Indian Oil Corp Ltd (IOC)：石油・ガス：M&Aディール及び事業提携情報
    Summary Indian Oil Corp Ltd (IOCL) is an integrated oil and gas company that carries out exploration and production of oil and natural gas, refining of crude oil, pipeline transportation and marketing of natural gas and petroleum products. The company also produces and markets petrochemicals and has …
  • Calliditas Therapeutics AB-製薬・医療分野：企業M&A・提携分析
    Summary Calliditas Therapeutics AB (Calliditas), formerly, Pharmalink AB is a pharmaceutical company that identifies, develops and commercializes pharmaceutical products for niche indications. The company’s product pipeline includes Nefecon for IgA Nephritis that is under Phase II clinical trials; a …
  • Cleveland HeartLab Inc-医療機器分野：企業M&A・提携分析
    Summary Cleveland HeartLab Inc (Cleveland HeartLab) is a clinical laboratory that provides cardiovascular testing services. The company offers services such as cardiovascular risk assessment, novel diagnostic tests, inflammatory and other advanced biomarker testing, management and prevention of hear …
  • Invion Ltd (IVX)：企業の財務・戦略的SWOT分析
    Summary Invion Ltd (Invion) is a life sciences company that develops products for the treatment of inflammatory diseases such as chronic inflammatory, airway disease and inflammation caused by autoimmune disease. The company's pipeline products include INV102 nadolol, a beta adrenergic biased ligand …
  • Tenaga Nasional Berhad (TENAGA)-エネルギー分野：企業M&A・提携分析
    Summary Tenaga Nasional Berhad (TNB) is an electricity utility that generates, transmits, distributes and supplies power. It develops, operates and maintains a portfolio of power generating units. The company produces electricity from crude oil, natural gas, hydro, coal and gas sources. TNB also sup …
  • Gulf Cement Company PSC：企業の戦略・SWOT・財務情報
    Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report Summary Gulf Cement Company PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Home Depot, Inc.：企業のM&A・事業提携・投資動向
    The Home Depot, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Home Depot, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Graphic Packaging Holding Company：戦略・SWOT・企業財務分析
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Enterprise Products Partners LP (EPD)-エネルギー分野：企業M&A・提携分析
    Summary Enterprise Products Partners L.P. (Enterprise Products) is a provider of midstream energy services. The company‘s integrated midstream operations include natural gas gathering, treating, processing, transportation and storage; natural gas liquid transportation, fractionation, storage, and im …
  • Lam Research Corporation：企業の戦略・SWOT・財務分析
    Lam Research Corporation - Strategy, SWOT and Corporate Finance Report Summary Lam Research Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PUMA SE：企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • CMIC Holdings Co Ltd (2309)：製薬・医療：M&Aディール及び事業提携情報
    Summary CMIC Holdings Co Ltd (CMIC) is a contract research organization that supports drug development services. The organization offers medical research related services to pharmaceuticals and medical organizations. Its CRO business services include monitoring, data management, STAT analysis, regis …
  • Bureau Veritas SA (BVI)-石油・ガス分野：企業M&A・提携分析
    Summary Bureau Veritas SA (Bureau Veritas) is a testing, inspection and certification service provider that offers varied services such as asset management, certification, classification, consulting, inspection and audits, testing and analysis, and training. The company serves aeronautics, agricultu …
  • InfuSystem Holdings Inc (INFU)：企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • Merck KGaA (MRK)-医療機器分野：企業M&A・提携分析
    Summary Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, O …
  • Gibson Energy Inc (GEI)-石油・ガス分野：企業M&A・提携分析
    Summary Gibson Energy Inc. (Gibson) is an independent midstream energy company that provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids (NGLs), water, oilfield waste, and refined prod …
  • United Energy Group Ltd (467)：石油・ガス：M&Aディール及び事業提携情報
    Summary United Energy Group Ltd (UEG) is an independent upstream oil and gas company that offers exploration and production of oil and gas reserves. The company's activities include merger and acquisition of oil and natural gas assets, exploitation, development and production of crude oil and natura …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆